Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

5 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 3

4(40.0%)

Phase 1

2(20.0%)

Phase 2

2(20.0%)

Phase 4

1(10.0%)

N/A

1(10.0%)

10Total

Phase 3(4)

Phase 1(2)

Phase 2(2)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT07412132Phase 3Recruiting

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

Role: collaborator

NCT03892655Active Not Recruiting

Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Role: lead

NCT07295587Enrolling By Invitation

Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd

Role: lead

NCT06808685Recruiting

Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie

Role: lead

NCT05920005Phase 3Completed

Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension

Role: collaborator

NCT06034561Phase 2Recruiting

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Role: collaborator

NCT04230408Phase 2Completed

Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers

Role: collaborator

NCT04928573Completed

Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab

Role: lead

NCT04373863Completed

Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population

Role: lead

NCT04271007Phase 4Completed

Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates

Role: lead

NCT05040672Completed

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees

Role: lead

NCT04622956Phase 1Unknown

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

Role: collaborator

NCT04455685Completed

Prevalence of Self-reported Premenstrual Syndrome and Analysis of Somatic and Psychoemotional Symptoms

Role: lead

NCT04342559Not ApplicableCompleted

Acceptability, Under Use in Real Conditions Of Two Vaginal Moistures Indicated for Women With Vaginal Drying

Role: lead

NCT04332978Phase 3Completed

Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene

Role: lead

NCT02268045Phase 3Completed

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Role: collaborator

NCT02069704Phase 1Completed

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Role: collaborator

All 17 trials loaded